2
Views
1
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Transcriptional Regulation of the Apolipoprotein B100 Gene: Purification and Characterization of trans -Acting Factor BRF-2

, &
Pages 3183-3191 | Received 04 Nov 1991, Accepted 16 Apr 1992, Published online: 01 Apr 2023

References

  • Borgmeyer, U., J. Nowock, and A. E. Sippel. 1984. The TGGCA-binding protein: a eukaryotic nuclear protein recognizing a symmetrical sequence on double stranded linear DNA. Nucleic Acids Res. 12:4295–4311.
  • Brooks, A. R., B. D. Blackhart, K. Haubold, and B. Levy-Wilson. 1991. Characterization of tissue-specific enhancer elements in the second intron of the human apolipoprotein Β gene. J. Biol. Chem. 266:7848–7859.
  • Carlsson, P., and G. Bjursell. 1989. Negative and positive promoter elements contribute to tissue specificity of apolipoprotein Β expression. Gene 77:113–121.
  • Carlsson, P., P. Eriksson, and G. Bjursell. 1990. Two nuclear proteins bind to the major positive element of the apolipoprotein Β gene promoter. Gene 94:295–301.
  • Collins, D. R., T. J. Knot, R. J. Pease, L. M. Powell, S. C. Wallis, S. Robertson, C. R. Pullinger, R. W. Milne, Y. L. Marcel, S. E. Humphries, P. J. Talmud, J. K. Lloyd, Ν. Ε. Miller, D. Muller, and J. Scot. 1988. Truncated variants of apolipoprotein Β cause hypobetalipoproteinemia. Nucleic Acids Res. 16:8361–8375.
  • Costa, R. R., D. R. Grayson, and J. E. Darnell, Jr. 1989. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and α1-antitrypsin genes. Mol. Cell. Biol. 9:1415–1425.
  • Courtois, G., J. G. Morgan, L. A. Campbell, G. Fourel, and G. R. Crabtree. 1987. Interaction of a liver-specific nuclear factor with fibrinogen and alpha 1-antitrypsin promoters. Science 238:688–692.
  • Das, Η. Κ., Τ. Leff, and J. L. Breslow. 1988. Cell type-specific expression of the human apoB gene is controlled by two cis-acting regulatory regions. J. Biol. Chem. 263:11452–11458.
  • Dignam, J. D., R. M. Lebowitz, and R. G. Roeder. 1983. Accurate transcription by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
  • Frain, M., G. Swart, P. Monaci, A. Nicosia, S. Stampfli, R. Frank, and R. Cortese. 1989. The liver-specific transcription factor LF-B1 contains a diverged homeobox DNA binding domain. Cell 59:145–157.
  • Goldstein, J. L., and M. S. Brown. 1977. The low density lipoprotein pathway and its relation to atherosclerosis. Annu. Rev. Biochem. 46:897–930.
  • Goldstein, J. L., and M. S. Brown. 1982. Familial hypercholesterolemia, p. 672–712. In J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. S. Brown (ed.), The metabolic basis of inherited disease, 5th ed. McGraw-Hill Book Co., New York.
  • Gorsky, C. Μ., Μ. Carneiro, and U. Schibler. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767–776.
  • Grayson, D. R., R. H. Costa, K. G. Xanthopoulos, and J. E. Darnell, Jr. 1988. One factor recognizes the liver-specific enhancers in alpha 1-antitrypsin and transthyretin genes. Science 239:786–788.
  • Havel, R. J., and J. P. Kane. 1989. Disorders of the biogenesis and secretion of lipoproteins containing the Β apolipoproteins, p. 1139–1164. In J. B. Stanbury, J. B. Wyngaarden, D. S. Frederickson, J. L. Goldstein, and M. S. Brown (ed.), The metabolic basis of inherited disease, 6th ed. McGraw-Hill Book Co., New York.
  • Johnson, P. F., W. H. Landschulz, B. J. Graves, and S. L. McKnight. 1987. Identification of a rat liver nuclear protein that binds to the core element of three animal viruses. Genes Dev. 1:133–146.
  • Kadonaga, J. T., and R. Tjian. 1986. Affinity purification of sequence-specific DNA binding proteins. Proc. Natl. Acad. Sci. USA 83:5889–5893.
  • Kannel, W. B., W. P. Castelli, and T. Gorton. 1979. Cholesterol in the prediction of atherosclerotic disease. Ann. Intern. Med. 90:85–91.
  • Kardassis, D., M. Hadzopoulou-Cladaras, D. P. Ramji, R. Cortese, V. I. Zannis, and C. Cladaras. 1990. Characterization of the promoter elements required for hepatic and intestinal transcription of the human apoB gene: definition of the DNA-binding site of a tissue-specific transcriptional factor. Mol. Cell. Biol. 10:2653–2659.
  • Kardassis, D., V. I. Zannis, and C. Cladaras. 1990. Purification and characterization of the nuclear factor BA1: a transcriptional activator of the human apoB gene. J. Biol. Chem. 265:21733–21740.
  • Kuwabara, M. D., and D. S. Sigman. 1987. Footprinting DNA-protein complexes in situ following gel retardation assays using 1,10 phenanthroline-copper ion: Escherichia coli RNA polymerase-lac promoter complexes. Biochemistry 26:7234–7238.
  • Ladias, J. Α. Α., and S. K. Karathanasis. 1991. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily. Science 251:561–565.
  • Lai, E., V. R. Prezioso, E. Smith, O. Litvin, R. H. Costa, and J. E. Darnell, Jr. 1990. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev. 4:1427–1436.
  • Lai, E., V. R. Prezioso, W. Tao, W. S. Chen, and J. E. Darnell, Jr. 1991. Hepatocyte nuclear factor 3 belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev. 5:416–427.
  • Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741–752.
  • Li, Y., R.-F. Shen, S. Y. Tsai, and S. L. C. Woo. 1988. Multiple hepatic trans-acting factors are required for in vitro transcription of the human alpha-1-antitrypsin gene. Mol. Cell. Biol. 8:4362–4369.
  • Lichtsteiner, S., J. Wuarin, and U. Schibler. 1987. The interplay of DNA-binding proteins on the promoter of the mouse albumin gene. Cell 51:963–973.
  • Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499–560.
  • Mendel, D. B., and G. R. Crabtree. 1991. HNF-1, a member of a novel class of dimerizing homeodomain proteins. J. Biol. Chem. 266:677–680.
  • Metzger, S., T. Leff, and J. L. Breslow. 1990. Nuclear factors AF-1 and C/EBP bind to the human apoB gene promoter and modulate its transcriptional activity in hepatic cells. J. Biol. Chem. 265:9978–9983.
  • Paonessa, G., F. Gounari, R. Frank, and R. Cortese. 1988. Purification of a NF1-like DNA-binding protein from rat liver and cloning of the corresponding cDNA. EMBO J. 7:3115–3123.
  • Raymondjean, M., S. Cereghini, and M. Yaniv. 1988. Several distinct "CCAAT" box binding proteins coexist in eukaryotic cells. Proc. Natl. Acad. Sci. USA 85:757–761.
  • Roy, N. K., and Η. Κ. Das. Unpublished data.
  • Saul, Y., R. Ben-Levy, and T. De-Medina. 1986. High affinity binding site for nuclear factor I next to hepatitis Β virus S gene promoter. EMBO J. 5:1967–1971.
  • Siervogel, R. M., J. A. Morrison, K. Kelly, M. Meliles, P. Gartside, and C. Glueck. 1980. Familial hyper-alpha-lipoproteinemia in 26 kindreds. J. Clin. Genet. 17:13.
  • Sladek, F. M., W. Zhong, E. Lai, and J. E. Darnell, Jr. 1990. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4:2353–2365.
  • Young, S. G., S. J. Bertices, L. K. Curtiss, B. W. Dubois, and J. L. Witztum. 1987. Genetic analysis of a kindred with familial hypobetalipoproteinemia, evidence for two separate gene defects: one associated with an abnormal apolipoprotein Β species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. J. Clin. Invest. 79:1842–1859.
  • Young, S. G., S. J. Bertices, L. K. Curtiss, and J. L. Witzum. 1987. Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia. J. Clin. Invest. 79:1831–1841.
  • Young, S. G., S. T. Northey, and B. J. McCarthy. 1988. Low plasma cholesterol levels caused by a short deletion of the apolipoprotein Β gene. Science 241:591–593.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.